Cargando…

A novel inflammatory biomarker, GlycA, associates with disease activity in rheumatoid arthritis and cardio-metabolic risk in BMI-matched controls

BACKGROUND: RA and CVD both have inflammation as part of the underlying biology. Our objective was to explore the relationships of GlycA, a measure of glycosylated acute phase proteins, with inflammation and cardiometabolic risk in RA, and explore whether these relationships were similar to those fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Bartlett, David B., Connelly, Margery A., AbouAssi, Hiba, Bateman, Lori A., Tune, K. Noelle, Huebner, Janet L., Kraus, Virginia B., Winegar, Deborah A., Otvos, James D., Kraus, William E., Huffman, Kim M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828830/
https://www.ncbi.nlm.nih.gov/pubmed/27067270
http://dx.doi.org/10.1186/s13075-016-0982-5
_version_ 1782426659172909056
author Bartlett, David B.
Connelly, Margery A.
AbouAssi, Hiba
Bateman, Lori A.
Tune, K. Noelle
Huebner, Janet L.
Kraus, Virginia B.
Winegar, Deborah A.
Otvos, James D.
Kraus, William E.
Huffman, Kim M.
author_facet Bartlett, David B.
Connelly, Margery A.
AbouAssi, Hiba
Bateman, Lori A.
Tune, K. Noelle
Huebner, Janet L.
Kraus, Virginia B.
Winegar, Deborah A.
Otvos, James D.
Kraus, William E.
Huffman, Kim M.
author_sort Bartlett, David B.
collection PubMed
description BACKGROUND: RA and CVD both have inflammation as part of the underlying biology. Our objective was to explore the relationships of GlycA, a measure of glycosylated acute phase proteins, with inflammation and cardiometabolic risk in RA, and explore whether these relationships were similar to those for persons without RA. METHODS: Plasma GlycA was determined for 50 individuals with mild-moderate RA disease activity and 39 controls matched for age, gender, and body mass index (BMI). Regression analyses were performed to assess relationships between GlycA and important markers of traditional inflammation and cardio-metabolic health: inflammatory cytokines, disease activity, measures of adiposity and insulin resistance. RESULTS: On average, RA activity was low (DAS-28 = 3.0 ± 1.4). Traditional inflammatory markers, ESR, hsCRP, IL-1β, IL-6, IL-18 and TNF-α were greater in RA versus controls (P < 0.05 for all). GlycA concentrations were significantly elevated in RA versus controls (P = 0.036). In RA, greater GlycA associated with disease activity (DAS-28; R(DAS-28) = 0.5) and inflammation (R(ESR) = 0.7, R(hsCRP) = 0.7, R(IL-6) = 0.3: P < 0.05 for all); in BMI-matched controls, these inflammatory associations were absent or weaker (hsCRP), but GlycA was related to IL-18 (R(hsCRP) = 0.3, R(IL-18) = 0.4: P < 0.05). In RA, greater GlycA associated with more total abdominal adiposity and less muscle density (R(abdominal-adiposity) = 0.3, R(muscle-density) = −0.3, P < 0.05 for both). In BMI-matched controls, GlycA associated with more cardio-metabolic markers: BMI, waist circumference, adiposity measures and insulin resistance (R = 0.3-0.6, P < 0.05 for all). CONCLUSIONS: GlycA provides an integrated measure of inflammation with contributions from traditional inflammatory markers and cardio-metabolic sources, dominated by inflammatory markers in persons with RA and cardio-metabolic factors in those without.
format Online
Article
Text
id pubmed-4828830
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-48288302016-04-13 A novel inflammatory biomarker, GlycA, associates with disease activity in rheumatoid arthritis and cardio-metabolic risk in BMI-matched controls Bartlett, David B. Connelly, Margery A. AbouAssi, Hiba Bateman, Lori A. Tune, K. Noelle Huebner, Janet L. Kraus, Virginia B. Winegar, Deborah A. Otvos, James D. Kraus, William E. Huffman, Kim M. Arthritis Res Ther Research Article BACKGROUND: RA and CVD both have inflammation as part of the underlying biology. Our objective was to explore the relationships of GlycA, a measure of glycosylated acute phase proteins, with inflammation and cardiometabolic risk in RA, and explore whether these relationships were similar to those for persons without RA. METHODS: Plasma GlycA was determined for 50 individuals with mild-moderate RA disease activity and 39 controls matched for age, gender, and body mass index (BMI). Regression analyses were performed to assess relationships between GlycA and important markers of traditional inflammation and cardio-metabolic health: inflammatory cytokines, disease activity, measures of adiposity and insulin resistance. RESULTS: On average, RA activity was low (DAS-28 = 3.0 ± 1.4). Traditional inflammatory markers, ESR, hsCRP, IL-1β, IL-6, IL-18 and TNF-α were greater in RA versus controls (P < 0.05 for all). GlycA concentrations were significantly elevated in RA versus controls (P = 0.036). In RA, greater GlycA associated with disease activity (DAS-28; R(DAS-28) = 0.5) and inflammation (R(ESR) = 0.7, R(hsCRP) = 0.7, R(IL-6) = 0.3: P < 0.05 for all); in BMI-matched controls, these inflammatory associations were absent or weaker (hsCRP), but GlycA was related to IL-18 (R(hsCRP) = 0.3, R(IL-18) = 0.4: P < 0.05). In RA, greater GlycA associated with more total abdominal adiposity and less muscle density (R(abdominal-adiposity) = 0.3, R(muscle-density) = −0.3, P < 0.05 for both). In BMI-matched controls, GlycA associated with more cardio-metabolic markers: BMI, waist circumference, adiposity measures and insulin resistance (R = 0.3-0.6, P < 0.05 for all). CONCLUSIONS: GlycA provides an integrated measure of inflammation with contributions from traditional inflammatory markers and cardio-metabolic sources, dominated by inflammatory markers in persons with RA and cardio-metabolic factors in those without. BioMed Central 2016-04-12 2016 /pmc/articles/PMC4828830/ /pubmed/27067270 http://dx.doi.org/10.1186/s13075-016-0982-5 Text en © Bartlett et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Bartlett, David B.
Connelly, Margery A.
AbouAssi, Hiba
Bateman, Lori A.
Tune, K. Noelle
Huebner, Janet L.
Kraus, Virginia B.
Winegar, Deborah A.
Otvos, James D.
Kraus, William E.
Huffman, Kim M.
A novel inflammatory biomarker, GlycA, associates with disease activity in rheumatoid arthritis and cardio-metabolic risk in BMI-matched controls
title A novel inflammatory biomarker, GlycA, associates with disease activity in rheumatoid arthritis and cardio-metabolic risk in BMI-matched controls
title_full A novel inflammatory biomarker, GlycA, associates with disease activity in rheumatoid arthritis and cardio-metabolic risk in BMI-matched controls
title_fullStr A novel inflammatory biomarker, GlycA, associates with disease activity in rheumatoid arthritis and cardio-metabolic risk in BMI-matched controls
title_full_unstemmed A novel inflammatory biomarker, GlycA, associates with disease activity in rheumatoid arthritis and cardio-metabolic risk in BMI-matched controls
title_short A novel inflammatory biomarker, GlycA, associates with disease activity in rheumatoid arthritis and cardio-metabolic risk in BMI-matched controls
title_sort novel inflammatory biomarker, glyca, associates with disease activity in rheumatoid arthritis and cardio-metabolic risk in bmi-matched controls
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828830/
https://www.ncbi.nlm.nih.gov/pubmed/27067270
http://dx.doi.org/10.1186/s13075-016-0982-5
work_keys_str_mv AT bartlettdavidb anovelinflammatorybiomarkerglycaassociateswithdiseaseactivityinrheumatoidarthritisandcardiometabolicriskinbmimatchedcontrols
AT connellymargerya anovelinflammatorybiomarkerglycaassociateswithdiseaseactivityinrheumatoidarthritisandcardiometabolicriskinbmimatchedcontrols
AT abouassihiba anovelinflammatorybiomarkerglycaassociateswithdiseaseactivityinrheumatoidarthritisandcardiometabolicriskinbmimatchedcontrols
AT batemanloria anovelinflammatorybiomarkerglycaassociateswithdiseaseactivityinrheumatoidarthritisandcardiometabolicriskinbmimatchedcontrols
AT tuneknoelle anovelinflammatorybiomarkerglycaassociateswithdiseaseactivityinrheumatoidarthritisandcardiometabolicriskinbmimatchedcontrols
AT huebnerjanetl anovelinflammatorybiomarkerglycaassociateswithdiseaseactivityinrheumatoidarthritisandcardiometabolicriskinbmimatchedcontrols
AT krausvirginiab anovelinflammatorybiomarkerglycaassociateswithdiseaseactivityinrheumatoidarthritisandcardiometabolicriskinbmimatchedcontrols
AT winegardeboraha anovelinflammatorybiomarkerglycaassociateswithdiseaseactivityinrheumatoidarthritisandcardiometabolicriskinbmimatchedcontrols
AT otvosjamesd anovelinflammatorybiomarkerglycaassociateswithdiseaseactivityinrheumatoidarthritisandcardiometabolicriskinbmimatchedcontrols
AT krauswilliame anovelinflammatorybiomarkerglycaassociateswithdiseaseactivityinrheumatoidarthritisandcardiometabolicriskinbmimatchedcontrols
AT huffmankimm anovelinflammatorybiomarkerglycaassociateswithdiseaseactivityinrheumatoidarthritisandcardiometabolicriskinbmimatchedcontrols
AT bartlettdavidb novelinflammatorybiomarkerglycaassociateswithdiseaseactivityinrheumatoidarthritisandcardiometabolicriskinbmimatchedcontrols
AT connellymargerya novelinflammatorybiomarkerglycaassociateswithdiseaseactivityinrheumatoidarthritisandcardiometabolicriskinbmimatchedcontrols
AT abouassihiba novelinflammatorybiomarkerglycaassociateswithdiseaseactivityinrheumatoidarthritisandcardiometabolicriskinbmimatchedcontrols
AT batemanloria novelinflammatorybiomarkerglycaassociateswithdiseaseactivityinrheumatoidarthritisandcardiometabolicriskinbmimatchedcontrols
AT tuneknoelle novelinflammatorybiomarkerglycaassociateswithdiseaseactivityinrheumatoidarthritisandcardiometabolicriskinbmimatchedcontrols
AT huebnerjanetl novelinflammatorybiomarkerglycaassociateswithdiseaseactivityinrheumatoidarthritisandcardiometabolicriskinbmimatchedcontrols
AT krausvirginiab novelinflammatorybiomarkerglycaassociateswithdiseaseactivityinrheumatoidarthritisandcardiometabolicriskinbmimatchedcontrols
AT winegardeboraha novelinflammatorybiomarkerglycaassociateswithdiseaseactivityinrheumatoidarthritisandcardiometabolicriskinbmimatchedcontrols
AT otvosjamesd novelinflammatorybiomarkerglycaassociateswithdiseaseactivityinrheumatoidarthritisandcardiometabolicriskinbmimatchedcontrols
AT krauswilliame novelinflammatorybiomarkerglycaassociateswithdiseaseactivityinrheumatoidarthritisandcardiometabolicriskinbmimatchedcontrols
AT huffmankimm novelinflammatorybiomarkerglycaassociateswithdiseaseactivityinrheumatoidarthritisandcardiometabolicriskinbmimatchedcontrols